April 20 (Reuters) - Gensight Biologics SA SIGHT.PA :
* GENSIGHT BIOLOGICS SA - CURRENT CASH RUNWAY TO JUNE 2023
* GENSIGHT BIOLOGICS SA - THREE PPQ BATCHES COULD BE
RELEASED FOR
HUMAN USE BY END OF YEAR
* GENSIGHT BIOLOGICS SA - CURRENTLY REVIEWING IMPACT OF
CURRENT
SITUATION ON EXISTING FINANCING
* GENSIGHT BIOLOGICS SA- CURRENT CASH RUNWAY TO JUNE 2023;
ADVANCED DISCUSSIONS ON FINANCING AND STRATEGIC OPTIONS
INCLUDING M&A ONGOING
* GENSIGHT BIOLOGICS SA - TAKING ADDITIONAL MEASURES AIMED
AT
SIGNIFICANTLY REDUCING ITS OPERATING CASH BURN IN 2023
* GENSIGHT BIOLOGICS SA - EXPECTS TO INITIATE VALIDATION
CAMPAIGN
IN MAY 2023, WITH RESULTS EXPECTED IN Q3 2023
Source text for Eikon: ID:nBw4bmbjma
Further company coverage: SIGHT.PA
((Reuters.Briefs@thomsonreuters.com;))